Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated

Julie B Herbstman1, Andreas Sjödin, Benjamin J Apelberg

  • 1Columbia Center for Children's Environmental Health, Department of Environmental Health Sciences, Columbia Mailman School of Public Health, New York, New York 10032, USA. jh2678@columbia.edu

Insights

Prenatal exposure to PCBs and PBDEs may lower thyroid hormones in infants born vaginally. Intrapartum stress might mask these chemical effects on developing babies.

Area of Science:

  • Environmental Health
  • Endocrinology
  • Toxicology

Background:

  • Developing infants are vulnerable to endocrine disruption from environmental chemicals.
  • Polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) are common chemical contaminants.
  • These chemicals may interfere with critical hormone development in newborns.

Purpose of the Study:

  • To examine the association between cord serum levels of PCBs and PBDEs and thyroid hormone levels in infants.
  • To investigate thyroid hormone measurements in both cord blood serum and neonatal blood spots.
  • To explore the influence of delivery mode as a factor in hormone disruption.

Main Methods:

  • Measured PCBs and PBDEs, thyrotropin (TSH), thyroxine (T4), and free T4 (FT4) in cord blood serum from 297 infants.
  • Abstracted total T4 (TT4) from neonatal blood spot samples.
  • Utilized delivery mode as a proxy for intrapartum stress, known to affect thyroid hormones.

Main Results:

  • No overall association found between chemical exposures and average TSH, FT4, or TT4 in the full cohort.
  • Specific PBDEs (BDE-100, BDE-153) were linked to increased odds of low cord TT4 and FT4.
  • In infants born via spontaneous vaginal delivery, PCBs were associated with lower cord TT4 and FT4, and PBDEs showed negative trends.

Conclusions:

  • Prenatal exposure to PCBs and PBDEs is associated with reduced TT4 and FT4 levels in infants born by spontaneous vaginal delivery.
  • The hormonal effects of these chemical exposures may be masked by intrapartum stress related to delivery mode.
  • Findings highlight the potential impact of environmental contaminants on infant thyroid hormone levels, particularly in the absence of significant delivery stress.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...